Oct 2026· International Journal of Women's Health· Vol 18· 0 citations· 24 references
Medicine
TL;DR
A standardized multicenter pilot is proposed comprising documented risk communication and a named receiving provider before discharge; blood-pressure evaluation within 72 hours for women with severe hypertension and no later than 7–10 days for other women with hypertensive disorders; structured assessment at 6–12 weeks and 6–12 months; permanent recording of hypertensive pregnancy history; and annual cardiovascular-risk review.
Abstract
Abstract Hypertensive disorders of pregnancy, particularly preeclampsia, identify women at increased risk of persistent hypertension and later cardiovascular disease, yet postpartum services often remain organized around short-term obstetric recovery. Thailand is well positioned to address this discontinuity because prospective local studies have demonstrated elevated blood pressure, hypertension, and selected cardiovascular and renal risk markers at 6 weeks and 6–12 months after preeclampsia or gestational hypertension. The principal policy gap is therefore not the absence of warning evidence, but the lack of a standardized and auditable handover from maternity services to primary care and cardiovascular prevention. This commentary was informed by a targeted, non-systematic examination of peer-reviewed studies, international professional recommendations, World Health Organization resources, and publicly accessible national guidance available in English through June 2026. Evidence was selected to characterize longer-term cardiovascular and renal risk following hypertensive disorders of pregnancy, summarize relevant Thai postpartum findings, and identify regional health-system approaches that could inform continuity of care in Thailand. Vietnam, Malaysia, and Mongolia were purposively selected as complementary examples of community noncommunicable-disease integration, local-clinic follow-up after hypertensive pregnancy, and continuity of care across geographic distance, respectively. We propose a standardized multicenter pilot comprising documented risk communication and a named receiving provider before discharge; blood-pressure evaluation within 72 hours for women with severe hypertension and no later than 7–10 days for other women with hypertensive disorders; structured assessment at 6–12 weeks and 6–12 months; permanent recording of hypertensive pregnancy history; and annual cardiovascular-risk review. National scale-up should follow evaluation of feasibility, completion, equity, and clinical outcomes. The aim is not to create a parallel specialty service, but to convert an established obstetric warning sign into accountable long-term cardiovascular and renal prevention.
Hypertensive disorders of pregnancy are increasingly recognized as early indicators of long-term maternal cardiovascular vulnerability rather than conditions limited to gestation. This study analyzed the association between hypertensive disorders of pregnancy and subsequent cardiovascular risk, with particular emphasis...
Adriana Patricia Núñez Manohatl, Jefferson Salguero-Sánchez, Alberto Macías Rodríguez et al.· IECCMEXICO· 0 citations
Introduction: The postpartum period is a clinically vulnerable stage for women with Hypertensive Disorders of Pregnancy (HDP), yet blood pressure surveillance commonly declines after discharge. Postpartum blood pressure monitoring is often not performed as recommended, resulting in an important monitoring gap.
Methodo...
G. Owusu· Majestic Multidisciplinary S...· 0 citations
Divergences between ACOG and international guidelines suggest opportunities to strengthen U.S. HDP prevention and management, including incorporating Black race and low income as independent aspirin prophylaxis risk criteria.
K. James, Alyssa A. Portes, Kandice A. Kapinos et al.· Birth· 0 citations
BACKGROUND
Hypertensive disorders of pregnancy (HDP) affect 8-10% of pregnancies. They are an important cause of maternal morbidity, with crucial implications for long-term cardiovascular health. Whilst antenatal blood pressure (BP) management is well described and evidence-based, postnatal treatment thresholds are hig...
Chloé Moran, Kimberly Lim Xinyi, Natalie Barry et al.· Pregnancy Hypertension· 0 citations
Current evidence regarding the classification, pathophysiology, acute and longitudinal management, and cardiovascular implications of postpartum hypertension is summarized, while emerging strategies to improve outcomes are highlighted.
Allison Payne, A. Hauspurg· Current Hypertension Reports· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.